Leppä, S.
92  results:
Search for persons X
?
1

The EHA Research Roadmap: Malignant Lymphoid Diseases:

Dreyling, M ; André, M ; Gökbuget, N...
info:eu-repo/semantics/altIdentifier/doi/10.1097/HS9.0000000000000726.  , 2022
 
?
2

P1135: SUBCUTANEOUS EPCORITAMAB IN COMBINATION WITH RITXUIM..:

Belada, D ; Leppä, S ; Wahlin, B. E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430698/.  , 2022
 
?
3

Feasibility of Combining the Phosphatidylinositol 3-Kinase ..:

Matasar M. J ; Dreyling M ; Leppa S...
info:eu-repo/semantics/altIdentifier/pmid/34389273.  , 2021
 
?
5

Long-term safety and efficacy of the PI3K- inhibitor copanl..:

Dreyling, M ; Santoro, A ; Mollica, L...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ajh.25711.  , 2019
 
?
6

Long-term safety and efficacy of the PI3K- inhibitor copanl..:

Dreyling, M ; Santoro, A ; Mollica, L...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ajh.25711.  , 2019
 
?
 
?
10

Up-front rituximab maintenance improves outcome in patients..:

Madsen, C ; Clausen, M R ; Plesner, T L...
https://pure.au.dk/portal/en/publications/43069652-bc7d-4bb0-8e8a-5670308a62b3.  , 2018
 
?
11

Up-front rituximab maintenance improves outcome in patients..:

Madsen, C ; Clausen, M R ; Plesner, T L...
https://vbn.aau.dk/da/publications/f2e90d5f-a443-4003-acce-7127199a4628.  , 2018
 
?
15

Alternative splicing discriminates molecular subtypes and h..:

Leivonen, S-K ; Taskinen, M ; Cervera, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596382/.  , 2017
 
1-15